scholarly article | Q13442814 |
P2093 | author name string | Dacheng Ren | |
Ali Adem Bahar | |||
P2860 | cites work | Mechanisms of cellular uptake of cell-penetrating peptides | Q21296784 |
A component of innate immunity prevents bacterial biofilm development | Q24298499 | ||
A helix propensity scale based on experimental studies of peptides and proteins | Q24537262 | ||
Riddle of biofilm resistance | Q24550611 | ||
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor | Q24569680 | ||
Crystal structure of the conserved core of the herpes simplex virus transcriptional regulatory protein VP16 | Q24602247 | ||
Sublancin is not a lantibiotic but an S-linked glycopeptide | Q24633863 | ||
Antimicrobial peptides and the skin immune defense system | Q24654981 | ||
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity | Q24675023 | ||
René Dubos: unearthing antibiotics | Q24677001 | ||
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein | Q24682905 | ||
Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA | Q24814019 | ||
Three-dimensional structure of RK-1: a novel alpha-defensin peptide | Q27628965 | ||
Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles | Q27628968 | ||
Three-Dimensional Structure in Lipid Micelles of the Pediocin-like Antimicrobial Peptide Sakacin P and a Sakacin P Variant That Is Structurally Stabilized by an Inserted C-Terminal Disulfide Bridge | Q27642235 | ||
Structure-based design of an indolicidin peptide analogue with increased protease stability | Q27642639 | ||
Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus | Q27642751 | ||
Antimicrobial peptides of multicellular organisms | Q28131811 | ||
Antibiotic resistance of bacteria in biofilms | Q28207706 | ||
Antifungal peptides: novel therapeutic compounds against emerging pathogens | Q28369443 | ||
Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin | Q28371536 | ||
LAMP: A Database Linking Antimicrobial Peptides | Q28534120 | ||
Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway | Q28612022 | ||
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
Mechanisms of biofilm resistance to antimicrobial agents | Q29615293 | ||
Pathways of clathrin-independent endocytosis | Q29620660 | ||
Persister cells | Q30018300 | ||
De novo design of α,β-didehydrophenylalanine containing peptides: From models to applications | Q30395902 | ||
A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. | Q30453404 | ||
Formation and characterization of a single Trp-Trp cross-link in indolicidin that confers protease stability without altering antimicrobial activity | Q30653838 | ||
Intracellular targets of antibacterial peptides | Q30688421 | ||
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections. | Q30788662 | ||
Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites | Q30826801 | ||
Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. | Q30836099 | ||
An anionic antimicrobial peptide from toad Bombina maxima | Q30837897 | ||
Bacterial evasion of antimicrobial peptides by biofilm formation. | Q36566225 | ||
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate | Q36779935 | ||
The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity | Q36801822 | ||
Antimicrobial peptides: natural effectors of the innate immune system | Q36875869 | ||
Cell-penetrating peptides in drug development: enabling intracellular targets | Q36883998 | ||
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. | Q36899142 | ||
Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides | Q36924383 | ||
Anti-antimicrobial peptides: folding-mediated host defense antagonists. | Q37012373 | ||
Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus | Q37040038 | ||
Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity | Q37051331 | ||
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum | Q37099451 | ||
Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. | Q37219123 | ||
Antimicrobial peptide GL13K is effective in reducing biofilms of Pseudomonas aeruginosa | Q37263735 | ||
Transcriptional regulation in bacterial membrane lipid synthesis | Q37305233 | ||
Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action | Q37377013 | ||
Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides | Q37385746 | ||
Anionic antimicrobial peptides from eukaryotic organisms. | Q37596463 | ||
Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides | Q37611973 | ||
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases | Q37624709 | ||
Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry | Q37730271 | ||
Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. | Q37807767 | ||
Alpha-helical cationic antimicrobial peptides: relationships of structure and function | Q37825833 | ||
Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. | Q37877621 | ||
Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs | Q37938364 | ||
Designing antimicrobial peptides: form follows function. | Q37968899 | ||
Human host defense peptide LL-37 prevents bacterial biofilm formation | Q38289682 | ||
Human cytomegalovirus binding to heparan sulfate proteoglycans on the cell surface and/or entry stimulates the expression of human leukocyte antigen class I. | Q38524197 | ||
Controlled release of antibiotics from coated orthopedic implants | Q38563246 | ||
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. | Q39119164 | ||
Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory | Q39251694 | ||
Salt-resistant alpha-helical cationic antimicrobial peptides. | Q39471096 | ||
Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase | Q39503102 | ||
The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides | Q39580785 | ||
Effects of Trp- and Arg-containing antimicrobial-peptide structure on inhibition of Escherichia coli planktonic growth and biofilm formation | Q39606752 | ||
Electrically gated ionic channels in lipid bilayers | Q39625257 | ||
ANTIBACTERIAL AND ENZYMIC BASIC PROTEINS FROM LEUKOCYTE LYSOSOMES: SEPARATION AND IDENTIFICATION | Q76576017 | ||
Amphipathic alpha helical antimicrobial peptides | Q77086082 | ||
Magainins as paradigm for the mode of action of pore forming polypeptides | Q77521430 | ||
Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin | Q78026511 | ||
Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms | Q81170513 | ||
Tuning the membrane selectivity of antimicrobial peptides by using multivalent design | Q81412600 | ||
Detergent-like properties of magainin antibiotic peptides: a 31P solid-state NMR spectroscopy study | Q81712241 | ||
Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants | Q82976691 | ||
Prevention of biofilm formation on titanium surfaces modified with conjugated molecules comprised of antimicrobial and titanium-binding peptides | Q84060745 | ||
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. | Q52296608 | ||
Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. | Q52544174 | ||
Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. | Q52545323 | ||
Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. | Q52565538 | ||
Structural characteristics of tenecin 3, an insect antifungal protein. | Q52569546 | ||
Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity. | Q52569762 | ||
Interaction between heat shock proteins and antimicrobial peptides. | Q52584182 | ||
Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. | Q53001349 | ||
Structure-activity relationship of HP (2-20) analog peptide: enhanced antimicrobial activity by N-terminal random coil region deletion. | Q53581006 | ||
All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. | Q54311933 | ||
Isolation and Characterization of Autolysis-Defective Mutants of Escherichia Coli that are Resistant to the Lytic Activity of Seminalplasmin | Q54330058 | ||
Chemical synthesis and biological evaluation of an antimicrobial peptide gonococcal growth inhibitor. | Q54337287 | ||
Antimicrobial dendrimer active against Escherichia coli biofilms. | Q54400219 | ||
Polymorphism in the Red Protein isolated from Milk of Individual Cows | Q59051140 | ||
Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system | Q59945098 | ||
The Effects of Histatin-derived Basic Antimicrobial Peptides on Oral Biofilms | Q60314978 | ||
Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds | Q68225927 | ||
Bacteriolytic activity of seminalplasmin | Q69005623 | ||
The NH2-terminal alpha-helical domain 1-18 of dermaseptin is responsible for antimicrobial activity | Q72739888 | ||
Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens | Q73076636 | ||
Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets | Q73157267 | ||
Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method | Q73729017 | ||
Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity | Q74038405 | ||
Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor | Q74061811 | ||
Mechanism of antimicrobial action of indolicidin | Q74291604 | ||
Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro | Q74338160 | ||
Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions | Q74352964 | ||
The lysozyme mechanism sorted -- after 50 years | Q74429085 | ||
The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers | Q74444933 | ||
Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid | Q31072339 | ||
Alpha,beta-dehydrophenylalanine containing cecropin-melittin hybrid peptides: conformation and activity. | Q31107485 | ||
Properties of a heparin-binding peptide derived from bovine lactoferrin | Q31962022 | ||
Peptide design by artificial neural networks and computer-based evolutionary search | Q32000547 | ||
Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.). | Q33200682 | ||
Antinematodal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Caenorhabditis elegans | Q33203154 | ||
QSAR modeling and computer-aided design of antimicrobial peptides | Q33298522 | ||
Antimicrobial peptides with stability toward tryptic degradation. | Q33321659 | ||
Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs | Q33389449 | ||
Identification of novel antibacterial peptides by chemoinformatics and machine learning | Q33419465 | ||
Post-translational modification and folding of a lasso-type gene-encoded antimicrobial peptide require two enzymes only in Escherichia coli. | Q33435864 | ||
Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. | Q33603089 | ||
Peptide antibiotics. | Q33647178 | ||
Antimicrobial and cytolytic polypeptides of amoeboid protozoa--effector molecules of primitive phagocytes | Q33699485 | ||
Optimization of antibacterial peptides by genetic algorithms and cheminformatics | Q33717391 | ||
Antimicrobial Peptides: Primeval Molecules or Future Drugs? | Q33742102 | ||
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread | Q33785801 | ||
Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity | Q33789711 | ||
Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. | Q33877111 | ||
In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action | Q33976229 | ||
The role of antimicrobial peptides in animal defenses | Q33988529 | ||
Amphipathic, alpha-helical antimicrobial peptides | Q33994626 | ||
Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide | Q34000667 | ||
Neutron scattering in the plane of membranes: structure of alamethicin pores | Q34017900 | ||
De novo design of biomimetic antimicrobial polymers | Q34023529 | ||
Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues. | Q34052854 | ||
Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration | Q34113328 | ||
Biofilm exopolysaccharides: a strong and sticky framework | Q34132041 | ||
Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide | Q34165875 | ||
Mechanisms of antimicrobial peptide action and resistance | Q34181099 | ||
Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation | Q34181441 | ||
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. | Q34286908 | ||
Identification of a novel antifungal peptide with chitin-binding property from marine metagenome | Q34293917 | ||
Intracellular receptor for human host defense peptide LL-37 in monocytes | Q39824888 | ||
Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine | Q40267880 | ||
Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. | Q40469485 | ||
Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action | Q40543015 | ||
Cationic antimicrobial peptides : issues for potential clinical use. | Q40570338 | ||
Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate | Q40608355 | ||
Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein | Q40763230 | ||
An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression | Q40856439 | ||
Seminalplasmin is a potent inhibitor of E. coli RNA polymerase in vitro | Q41053144 | ||
D-amino acids in animal peptides | Q41550207 | ||
Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process | Q41714058 | ||
STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS : II. PROTECTIVE EFFECT OF THE BACTERICIDAL AGENT AGAINST EXPERIMENTAL PNEUMOCOCCUS INFECTIONS IN MICE | Q41832776 | ||
Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum | Q41899120 | ||
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. | Q41906637 | ||
Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. | Q41973626 | ||
Insect Immunity. Purification and Properties of Three Inducible Bactericidal Proteins from Hemolymph of Immunized Pupae of Hyalophora cecropia | Q42077725 | ||
Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm | Q42110066 | ||
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. | Q42112409 | ||
Purification and characterization of a diptericin homologue from Sarcophaga peregrina (flesh fly) | Q42161445 | ||
Short cationic antimicrobial peptides interact with ATP. | Q42421193 | ||
Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. | Q42544979 | ||
STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS : I. PREPARATION OF THE AGENT. ITS ACTIVITY IN VITRO. | Q42802150 | ||
THE PRODUCTION OF BACTERICIDAL SUBSTANCES BY AEROBIC SPORULATING BACILLI. | Q42812690 | ||
Phagocytin: a bactericidal substance from polymorphonuclear leucocytes | Q42822278 | ||
Antimicrobial peptides in frog skin secretions. | Q43186257 | ||
The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding | Q43547658 | ||
Interaction of cationic antimicrobial peptides with model membranes | Q43687963 | ||
Development of a nose cream containing the synthetic antimicrobial peptide P60.4Ac for eradication of methicillin-resistant Staphylococcus aureus carriage | Q43702971 | ||
Bacterial modification of LPS and resistance to antimicrobial peptides | Q43718689 | ||
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase | Q43820230 | ||
In vitro antiviral activity of dermaseptins against herpes simplex virus type 1. | Q43849033 | ||
Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum | Q44056487 | ||
Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. | Q44082508 | ||
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. | Q44121026 | ||
Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. | Q44158394 | ||
Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci | Q44198704 | ||
Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata | Q44249496 | ||
Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. | Q44305012 | ||
Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology | Q44342523 | ||
Complete primary structures of two subunits of purothionin A, a lethal protein for brewer's yeast from wheat flour | Q44386714 | ||
Fungicidal effect of indolicidin and its interaction with phospholipid membranes | Q44439718 | ||
Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils | Q44563317 | ||
Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. | Q44691974 | ||
Persister cells and tolerance to antimicrobials | Q44735515 | ||
Structure and fungicidal activity of a synthetic antimicrobial peptide, P18, and its truncated peptides | Q44823405 | ||
Recombinant expression and purification of the antimicrobial peptide magainin-2. | Q44960277 | ||
Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin | Q45105736 | ||
Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis | Q45123079 | ||
The role of antimicrobial peptides in innate immunity. | Q45972725 | ||
Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis | Q46044268 | ||
Membrane thinning caused by magainin 2. | Q46338877 | ||
Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin. | Q46792867 | ||
Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application | Q46869207 | ||
The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity | Q47732388 | ||
Design and activity of novel lactoferrampin analogues against O157:H7 enterohemorrhagic Escherichia coli. | Q47955240 | ||
Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. | Q48085697 | ||
Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation. | Q49016487 | ||
Recognition of antimicrobial peptides by a bacterial sensor kinase. | Q50088065 | ||
C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria. | Q50444842 | ||
Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. | Q50480264 | ||
Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. | Q50518048 | ||
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes | Q50787783 | ||
A linguistic model for the rational design of antimicrobial peptides. | Q51116525 | ||
Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance. | Q52291008 | ||
Magainins and the disruption of membrane-linked free-energy transduction | Q34300587 | ||
Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. | Q34352478 | ||
Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. | Q34356262 | ||
A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus | Q34377886 | ||
Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index | Q34432501 | ||
Computational studies of protegrin antimicrobial peptides: a review. | Q34455757 | ||
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli | Q34503697 | ||
Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family | Q34745204 | ||
NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2 | Q34822004 | ||
Control of cell selectivity of antimicrobial peptides | Q34865746 | ||
Mode of action of membrane active antimicrobial peptides | Q35030295 | ||
Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. | Q35107961 | ||
Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial | Q35137422 | ||
Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides | Q35138938 | ||
A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats. | Q35551129 | ||
Cathelicidin family of antimicrobial peptides: proteolytic processing and protease resistance | Q35582184 | ||
The relationship between peptide structure and antibacterial activity | Q35690395 | ||
Treatment of infections associated with surgical implants | Q35740678 | ||
Anti-microbial peptides: from invertebrates to vertebrates. | Q35806874 | ||
Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm | Q35903859 | ||
Folding amphipathic helices into membranes: amphiphilicity trumps hydrophobicity | Q36082510 | ||
Antibacterial peptides and proteins with multiple cellular targets | Q36214382 | ||
Cationic host defense (antimicrobial) peptides | Q36335785 | ||
Isolation of achatin-I, a neuroactive tetrapeptide having a D-phenylalanine residue, from Achatina ganglia, and its effects on Achatina giant neurones | Q36494317 | ||
Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens | Q36505406 | ||
Peptide antimicrobial agents | Q36538861 | ||
Antibacterial peptides for therapeutic use: obstacles and realistic outlook | Q36556909 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antimicrobial peptide | Q1201508 |
antimicrobial humoral immune response mediated by antimicrobial peptide | Q28598481 | ||
P304 | page(s) | 1543-75 | |
P577 | publication date | 2013-11-28 | |
P1433 | published in | Pharmaceuticals | Q15750667 |
P1476 | title | Antimicrobial peptides | |
P478 | volume | 6 |
Q33766309 | A Chitin-binding Protein Purified from Moringa oleifera Seeds Presents Anticandidal Activity by Increasing Cell Membrane Permeability and Reactive Oxygen Species Production |
Q97419353 | A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of Klebsiella pneumoniae and Pseudomonas aeruginosa |
Q36177946 | A Novel Defensin-Like Peptide Associated with Two Other New Cationic Antimicrobial Peptides in Transcriptome of the Iranian Scorpion Venom |
Q64235912 | A Periplasmic Antimicrobial Peptide-Binding Protein Is Required for Stress Survival in |
Q90302756 | A coarse-grained approach to studying the interactions of the antimicrobial peptides aurein 1.2 and maculatin 1.1 with POPG/POPE lipid mixtures |
Q91718483 | A novel recombinant javanicin with dual antifungal and anti-proliferative activities |
Q60916150 | Action of Antimicrobial Peptides against Bacterial Biofilms |
Q28082463 | Active targeted drug delivery for microbes using nano-carriers |
Q98950884 | Activity of Temporin A and Short Lipopeptides Combined with Gentamicin against Biofilm Formed by Staphylococcus aureus and Pseudomonas aeruginosa |
Q57041845 | Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms |
Q47555981 | AmPEP: Sequence-based prediction of antimicrobial peptides using distribution patterns of amino acid properties and random forest |
Q48231448 | Amphipathic guanidine-embedded glyoxamide-based peptidomimetics as novel antibacterial agents and biofilm disruptors. |
Q38990711 | An efficient liquid chromatography-high resolution mass spectrometry approach for the optimization of the metabolic stability of therapeutic peptides. |
Q26750570 | Antibacterial Derivatives of Marine Algae: An Overview of Pharmacological Mechanisms and Applications |
Q51555343 | Antibacterial Peptide CecropinB2 Production via Various Host and Construct Systems. |
Q35867318 | Antibacterial Peptide-Based Gel for Prevention of Medical Implanted-Device Infection |
Q50002310 | Antibacterial Peptides in Dermatology-Strategies for Evaluation of Allergic Potential. |
Q53568412 | Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria. |
Q91650098 | Antifungal Peptides as Therapeutic Agents |
Q37727501 | Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies |
Q58693719 | Antimicrobial Activity of NCR Plant Peptides Strongly Depends on the Test Assays |
Q60916381 | Antimicrobial Effects of Biogenic Nanoparticles |
Q36439097 | Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli |
Q64928948 | Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids. |
Q42652970 | Antimicrobial Peptides Secreted From Human Cryopreserved Viable Amniotic Membrane Contribute to its Antibacterial Activity |
Q55053689 | Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges. |
Q64949568 | Antimicrobial Peptides: Potential Application in Liver Cancer. |
Q52663552 | Antimicrobial Photodynamic therapy enhanced by the peptide aurein 1.2. |
Q90197306 | Antimicrobial activity and mechanism of action of a novel peptide present in the ecdysis process of centipede Scolopendra subspinipes subspinipes |
Q45317095 | Antimicrobial peptides |
Q41821325 | Antimicrobial peptides and their analogs: searching for new potential therapeutics. |
Q38989893 | Antimicrobial peptides as natural bio-preservative to enhance the shelf-life of food |
Q61799068 | Antimicrobial peptides from Rana [Lithobates] catesbeiana: Gene structure and bioinformatic identification of novel forms from tadpoles |
Q33869297 | Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds |
Q53695827 | Antimicrobial peptides: biochemical determinants of activity and biophysical techniques of elucidating their functionality. |
Q58116011 | Antimicrobial peptides: recent insights on biotechnological interventions and future perspectives |
Q38936638 | Antioxidative and antibacterial peptides derived from bovine milk proteins |
Q90461586 | Antiseptic Effect of Ps-K18: Mechanism of Its Antibacterial and Anti-Inflammatory Activities |
Q58765926 | Antitumor Ability of KT2 Peptide Derived from Leukocyte Peptide of Crocodile Against Human HCT116 Colon Cancer Xenografts |
Q28353903 | Antiviral activity of animal venom peptides and related compounds |
Q46425422 | Application and bioactive properties of CaTI, a trypsin inhibitor from Capsicum annuum seeds: membrane permeabilization, oxidative stress and intracellular target in phytopathogenic fungi cells. |
Q41844800 | Bacteria May Cope Differently from Similar Membrane Damage Caused by the Australian Tree Frog Antimicrobial Peptide Maculatin 1.1. |
Q40153879 | Bacteria-Assisted Activation of Antimicrobial Polypeptides by a Random-Coil to Helix Transition |
Q36315932 | Bacterial danger sensing |
Q64080741 | Bactericidal activity of 3D-printed hydrogel dressing loaded with gallium maltolate |
Q55263222 | Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria. |
Q40161010 | Beyond antibiotic therapy - Future antiinfective strategies - Update 2017 |
Q40203926 | Bifunctional antimicrobial conjugates and hybrid antimicrobials |
Q92733951 | Binding and Flip as Initial Steps for BP-100 Antimicrobial Actions |
Q39369482 | Bioactive peptides derived from egg proteins: A review |
Q89571075 | Bioinspired Designs, Molecular Premise and Tools for Evaluating the Ecological Importance of Antimicrobial Peptides |
Q38393301 | Biologically active and antimicrobial peptides from plants. |
Q93052193 | Bombardier Enables Delivery of Short-Form Bomanins in the Drosophila Toll Response |
Q92472834 | Cationic Amphiphiles with Specificity against Gram-Positive and Gram-Negative Bacteria: Chemical Composition and Architecture Combat Bacterial Membranes |
Q38774418 | Cationic Antimicrobial Peptides Derived from Crocodylus siamensis Leukocyte Extract, Revealing Anticancer Activity and Apoptotic Induction on Human Cervical Cancer Cells |
Q90652794 | Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens |
Q92259169 | Cell Membrane-Interrupting Antimicrobial Peptides from Isatis indigotica Fortune Isolated by a Bacillus subtilis Expression System |
Q38805820 | Characterizing the structure-function relationship reveals the mode of action of a novel antimicrobial peptide, P1, from jumper ant Myrmecia pilosula |
Q40540795 | Clinical potential of engineered cationic antimicrobial peptides against drug resistant biofilms |
Q42102649 | Comparative Analysis of the Bacterial Membrane Disruption Effect of Two Natural Plant Antimicrobial Peptides |
Q64063027 | Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa |
Q92541418 | Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections |
Q35810321 | Controlling Persister and Biofilm Cells of Gram-Negative Bacteria with a New 1,3,5-Triazine Derivative |
Q36464024 | Convenient synthesis of collagen-related tripeptides for segment condensation |
Q90267349 | CrossTalk proposal: mucosal acidification drives early progressive lung disease in cystic fibrosis |
Q51373454 | Crosslinked Platform Coatings Incorporating Bioactive Signals for the Control of Biointerfacial Interactions. |
Q36382760 | Current state of a dual behaviour of antimicrobial peptides-Therapeutic agents and promising delivery vectors |
Q53834355 | Current trends and perspectives of bioactive peptides. |
Q36284044 | De novo assembly of the sea trout (Salmo trutta m. trutta) skin transcriptome to identify putative genes involved in the immune response and epidermal mucus secretion |
Q92070018 | Dermaseptins, Multifunctional Antimicrobial Peptides: A Review of Their Pharmacology, Effectivity, Mechanism of Action, and Possible Future Directions |
Q64079385 | Design and characterization of a new hybrid peptide from LL-37 and BMAP-27 |
Q38485480 | Designing drugs that overcome antibacterial resistance: where do we stand and what should we do? |
Q47753580 | Differential Interaction of Antimicrobial Peptides with Lipid Structures Studied by Coarse-Grained Molecular Dynamics Simulations |
Q50145481 | Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries |
Q35222585 | Discovery of modulators of HIV-1 infection from the human peptidome |
Q41030976 | Docking small peptides remains a great challenge: an assessment using AutoDock Vina |
Q40252726 | Droplet-based non-faradaic impedance sensors for assessment of susceptibility of Escherichia coli to ampicillin in 60 min. |
Q47158624 | EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA) |
Q92346221 | Effect of fosfomycin, Cynara scolymus extract, deoxynivalenol and their combinations on intestinal health of weaned piglets |
Q35177948 | Effect of recombinant prophenin 2 on the integrity and viability of Trichomonas vaginalis |
Q35923005 | Effects of neutrophils peptide-1 transgenic Chlorella ellipsoidea on the gut microbiota of male Sprague-Dawley rats, as revealed by high-throughput 16S rRNA sequencing |
Q90380036 | Efflux pumps and antimicrobial resistance: Paradoxical components in systems genomics |
Q91962800 | Epinecidin-1 Protects against Methicillin Resistant Staphylococcus aureus Infection and Sepsis in Pyemia Pigs |
Q38814378 | Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides. |
Q34809662 | Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications |
Q57466029 | Fine-tuning carbapenem resistance by reducing porin permeability of bacteria activated in the selection process of conjugation |
Q92727312 | Flagella-dependent inhibition of biofilm formation by sub-inhibitory concentration of polymyxin B in Vibrio cholerae |
Q50060109 | G.I. pros: Antimicrobial defense in the gastrointestinal tract |
Q40052657 | Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens |
Q96303297 | Green synthesis of peptide functionalized reduced graphene oxide (rGO) nano bioconjugate with enhanced antibacterial activity |
Q39281980 | Guardians of the Gut: Enteric Defensins |
Q47130278 | Hairpin structure stability plays a role in the activity of two antimicrobial peptides |
Q36238251 | Helical antimicrobial polypeptides with radial amphiphilicity |
Q49278192 | Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides |
Q96304682 | Honey Bee Suppresses the Parasitic Mite Vitellogenin by Antimicrobial Peptide |
Q92372793 | Human Antimicrobial Peptides as Therapeutics for Viral Infections |
Q48250595 | Hydrocarbon Stapled Antimicrobial Peptides. |
Q64252468 | IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense |
Q46347517 | Identification of Bufadienolides from the Boreal Toad, Anaxyrus boreas, Active Against a Fungal Pathogen |
Q94561442 | Identification of the Molecular Determinants Involved in Antimicrobial Activity of Pseudodesmin A, a Cyclic Lipopeptide From the Viscosin Group |
Q40476669 | Imbalanced multi-label learning for identifying antimicrobial peptides and their functional types. |
Q91795689 | Incorporation of non-standard amino acids into proteins: challenges, recent achievements, and emerging applications |
Q90332527 | Influence of Acyl Chain Saturation on the Membrane-Binding Activity of a Short Antimicrobial Peptide |
Q84316043 | Insilico Alpha-Helical Structural Recognition of Temporin Antimicrobial Peptides and Its Interactions with Middle East Respiratory Syndrome-Coronavirus |
Q40355262 | Interaction of aurein 1.2 and its analogue with DPPC lipid bilayer |
Q60342834 | Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts |
Q48349019 | Isolation and characterization of an anti-leishmanial disintegrin from Cerastes cerastes venom |
Q59355341 | LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells |
Q57023857 | Leishmania, microbiota and sand fly immunity |
Q59312948 | Linker-free covalent immobilization of nisin using atmospheric pressure plasma induced grafting |
Q61832610 | Lipid coated liquid crystal droplets for the on-chip detection of antimicrobial peptides |
Q44385177 | Lipid-packing perturbation of model membranes by pH-responsive antimicrobial peptides |
Q47117344 | Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria |
Q48147388 | Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa. |
Q92538088 | Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions |
Q93004943 | Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk |
Q61816837 | Melittin Inhibition and Eradication Activity for Resistant Polymicrobial Biofilm Isolated from a Dairy Industry after Disinfection |
Q48310540 | Membrane negative curvature induced by a hybrid peptide from pediocin PA-1 and plantaricin 149 as revealed by atomistic molecular dynamics simulations |
Q92252011 | Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability |
Q55163192 | Modes of Action of a Bi-domain Plant Defensin MtDef5 Against a Bacterial Pathogen Xanthomonas campestris. |
Q89944374 | Molecular Profiling of Keratinocyte Skin Tumors Links Staphylococcus aureus Overabundance and Increased Human β-Defensin-2 Expression to Growth Promotion of Squamous Cell Carcinoma |
Q37170303 | Mutation of the Enterohemorrhagic Escherichia coli Core LPS Biosynthesis Enzyme RfaD Confers Hypersusceptibility to Host Intestinal Innate Immunity In vivo |
Q57177419 | Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans" |
Q92393023 | Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications |
Q40104332 | Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing |
Q37248305 | Nematode Peptides with Host-Directed Anti-inflammatory Activity Rescue Caenorhabditis elegans from a Burkholderia pseudomallei Infection |
Q89172115 | New Innovations in the Treatment of PJI and Biofilms-Clinical and Preclinical Topics |
Q52313190 | New Insights Into the Mechanisms and Biological Roles of D-Amino Acids in Complex Eco-Systems. |
Q40195691 | New Potent Membrane-Targeting Antibacterial Peptides from Viral Capsid Proteins |
Q100694511 | NoPv1: a synthetic antimicrobial peptide aptamer targeting the causal agents of grapevine downy mildew and potato late blight |
Q36119903 | Novel haemoglobin-derived antimicrobial peptides from chicken (Gallus gallus) blood: purification, structural aspects and biological activity |
Q90241788 | Novel mitochondrial complex I-inhibiting peptides restrain NADH dehydrogenase activity |
Q46309064 | Nuclease activity gives an edge to host-defense peptide piscidin 3 over piscidin 1, rendering it more effective against persisters and biofilms. |
Q39369758 | On the challenges of detecting whole Staphylococcus aureus cells with biosensors |
Q94536794 | Optimizing Cell-Free Protein Synthesis for Increased Yield and Activity of Colicins |
Q64084910 | PACAP Is Lethal to Through Either Direct Membrane Permeabilization or Indirectly, by Priming the Immune Response in Rainbow Trout Macrophages |
Q36565575 | PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells |
Q40614393 | ParaPep: a web resource for experimentally validated antiparasitic peptide sequences and their structures |
Q56603817 | PepSAVI-MS reveals anticancer and antifungal cycloviolacins in Viola odorata |
Q36309109 | Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity |
Q37554509 | Piscidin-1-analogs with double L- and D-lysine residues exhibited different conformations in lipopolysaccharide but comparable anti-endotoxin activities |
Q38847017 | Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections. |
Q37009418 | Prediction of Biofilm Inhibiting Peptides: An In silico Approach |
Q38241687 | Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria |
Q92178495 | Prospecting Peptides Isolated From Black Soldier Fly (Diptera: Stratiomyidae) With Antimicrobial Activity Against Helicobacter pylori (Campylobacterales: Helicobacteraceae) |
Q40721316 | Rational Evolution of Antimicrobial Peptides Containing Unnatural Amino Acids to Combat Burn Wound Infections |
Q52391083 | Recent Advances in the Synthesis of Peptoid Macrocycles. |
Q40107966 | Recent Developments in Antimicrobial Polymers: A Review. |
Q37201360 | Role of Antimicrobial Peptides in Amphibian Defense Against Trematode Infection |
Q48104649 | Role of Cationic Side Chains in the Antimicrobial Activity of C18G. |
Q26744734 | Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides |
Q91846101 | Roles of two-component regulatory systems in antibiotic resistance |
Q92493195 | Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions |
Q36160517 | Sarkosyl-Induced Helical Structure of an Antimicrobial Peptide GW-Q6 Plays an Essential Role in the Binding of Surface Receptor OprI in Pseudomonas aeruginosa |
Q46719331 | Self-assembling dipeptide antibacterial nanostructures with membrane disrupting activity. |
Q39077320 | Structural and Dynamic Insights of the Interaction between Tritrpticin and Micelles: An NMR Study |
Q37713223 | Structure and Function of AApeptides. |
Q64921445 | Sub-inhibitory Effects of Antimicrobial Peptides. |
Q91656653 | Surface Grafted MSI-78A Antimicrobial Peptide has High Potential for Gastric Infection Management |
Q90618740 | Susceptibility of Multidrug-Resistant Bacteria, Isolated from Water and Plants in Nigeria, to Ceragenins |
Q59808687 | Synergistic Effect of Quinic Acid Derived From and Undecanoic Acid Against spp. Biofilm and Virulence |
Q47747181 | Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa |
Q50869052 | Synthesis and biological evaluation of N-naphthoyl-phenylglyoxamide-based small molecular antimicrobial peptide mimics as novel antimicrobial agents and biofilm inhibitors. |
Q40296898 | Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. |
Q53841542 | Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa. |
Q52590840 | Tackling Salmonella Persister Cells by Antibiotic-Nisin Combination via Mannitol. |
Q40227991 | Tat-functionalized liposomes for the treatment of meningitis: an in vitro study |
Q91638638 | Testing a Human Antimicrobial RNase Chimera Against Bacterial Resistance |
Q38552370 | The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides. |
Q89138142 | The Solution Structure of CCL28 Reveals Structural Lability that Does Not Constrain Antifungal Activity |
Q45324623 | The antimicrobial peptide HS-1 inhibits dengue virus infection. |
Q92023577 | The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection |
Q83230727 | The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in |
Q92511937 | The antimicrobial peptides and their potential clinical applications |
Q50214791 | The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus |
Q35652933 | The application of antimicrobial peptides as growth and health promoters for swine. |
Q36024399 | The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules |
Q50889058 | The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity. |
Q47742901 | Topographical diversity of common skin microflora and its association with skin environment type: An observational study in Chinese women |
Q89400813 | Towards mapping electrostatic interactions between Kdo2-lipid A and cationic antimicrobial peptides via ultraviolet photodissociation mass spectrometry |
Q33695068 | Transcriptional Responses of Candida albicans to Antimicrobial Peptide MAF-1A |
Q98164417 | Transcriptome profiling and in silico detection of the antimicrobial peptides of red king crab Paralithodes camtschaticus |
Q41404407 | Transcriptomic profiling of microbe-microbe interactions reveals the specific response of the biocontrol strain P. fluorescens In5 to the phytopathogen Rhizoctonia solani. |
Q26997004 | Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools |
Q52609589 | Tryptophan-Rich and Proline-Rich Antimicrobial Peptides. |
Q33579842 | Variations in the interaction of human defensins with Escherichia coli: Possible implications in bacterial killing |
Q39205415 | β-Boomerang Antimicrobial and Antiendotoxic Peptides: Lipidation and Disulfide Bond Effects on Activity and Structure |
Search more.